CPT® Code 81161

The CPT® Code 81161 pertains to molecular genetic testing specifically aimed at identifying deletions and duplications in the dystrophin gene, which is crucial for diagnosing Duchenne and Becker muscular dystrophies. These conditions are among the most prevalent neuromuscular disorders diagnosed during childhood, primarily affecting males due to their X-linked genetic inheritance. Duchenne muscular dystrophy (DMD) is characterized by a more severe clinical course, typically presenting symptoms by the age of three, leading to significant loss of mobility by ages nine or ten, and often resulting in premature death by the age of twenty. In contrast, Becker muscular dystrophy (BMD) has a slower progression, with affected individuals usually living into their 30s or 40s. The testing for these muscular dystrophies involves analyzing the dystrophin gene located at Xp21 for any deletions or duplications, which can be accomplished through various molecular techniques such as Southern blotting with complementary DNA (cDNA) probes or polymerase chain reaction (PCR). The inclusion of gene duplication analysis in the CPT® Code 81161 ensures comprehensive testing for both types of genetic anomalies associated with these muscular dystrophies.